Overview
Axon Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule treatments targeting synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
More in Neuropharmaceuticals
Latest industry news
China's Neurotech Ambitions Signal a New Frontier in the Global Brain Race
2026-10-18 · Industry
Functional Ultrasound BCIs Cross a Threshold: From Brain Reading to Two-Way Control
2026-10-17 · Research
Visual Cues Are Quietly Skewing BCI Accuracy Scores, and the Field Is Taking Notice
2026-10-16 · Research
ReVision Implant Secures €4 Million to Advance Neural Vision Restoration Technology
2026-10-15 · Funding
Company details
Category
💊 Neuropharmaceuticals
Location
San Diego, CA
Funding
Series B
Website
axontherapeutics.comListed
2026-09-28
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →